Search Results

If you make changes to this saved search, you'll find the original and new searches in your account.

Your search filters:

CicloMed

Showing 1-2 of about 2 articles.

CicloMed LLC

CicloMed Announces First Patient Dosed with Ciclopirox Prodrug in Phase I Trial in Patients with Advanced Solid Tumors

KANSAS CITY, Mo., Feb. 28, 2018 (GLOBE NEWSWIRE) -- CicloMed LLC, a biotechnology company developing novel treatments for bladder cancer, today announced that the first patient has been dosed in a ...

February 28, 2018

CicloMed LLC

CicloMed Announces FDA Clearance of IND Application for Ciclopirox Prodrug in the Treatment of Bladder Cancer

KANSAS CITY, Mo., Oct. 11, 2017 (GLOBE NEWSWIRE) -- CicloMed LLC announced today that its development candidate for non-muscle-invasive and muscle-invasive bladder cancer, Ciclopirox Prodrug, was ...

October 11, 2017

Showing 1-2 of about 2 articles.

CicloMed Announces First Patient Dosed with Ciclopirox Prodrug in Phase I Trial in Patients with Advanced Solid Tumors

CicloMed Announces FDA Clearance of IND Application for Ciclopirox Prodrug in the Treatment of Bladder Cancer

Newswire Distribution Network & Management

About Us